Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 22246-18-0
2. 7-hydroxy-3,4-dihydroquinolin-2(1h)-one
3. 7-hydroxy-3,4-dihydro-2(1h)-quinolinone
4. 7-hydroxy-3,4-dihydro-1h-quinolin-2-one
5. 3,4-dihydro-7-hydroxycarbostyril
6. 7-hydroxy-3,4-dihydrocarbostyril
7. 7-hydroxy-3,4-dihydro-quinolin-2-one
8. 3,4-dihydroquinoline-2,7-diol
9. 2(1h)-quinolinone, 3,4-dihydro-7-hydroxy-
10. Vfu6xcr3q3
11. Chembl2430711
12. Mfcd06410891
13. 3,4-dihydro-7-hydroxy-2(1h)-quinoline
14. 3,4-dihydro-7-hydroxyquinoline-2(1h)-one
15. 7-hydroxy-1,2,3,4-tetrahydroquinolin-2-one
16. 7-oxidanyl-3,4-dihydro-1~{h}-quinolin-2-one
17. 7-hydroxy-3,4-dihydro Carbostyril
18. Unii-vfu6xcr3q3
19. Aripiprazole Impurity 13
20. Aripiprazole Ep Impurity A
21. Schembl8751
22. Aripiprazole Impurity A [ep]
23. Dtxsid70382941
24. 7-hydroxy-3,4-dihydro-carbostyril
25. Bcp27862
26. Zinc3957997
27. Bbl011056
28. Bdbm50493470
29. S4767
30. Stk617335
31. Stk802230
32. Akos005551353
33. Akos005622540
34. Ab25068
35. Ac-7028
36. Ccg-266302
37. Cs-w010846
38. Fd18013
39. Gf-0122
40. Hy-w010130
41. Sy009657
42. 7-hydroxy-3,4-dihydro-1h-quinoline-2-one
43. 7-hydroxy-3,4-dihydro-2(1h)-quinolineone
44. 7-hydroxy-3,4-dihydro-quinolin-2(1h)-one
45. Am20060553
46. Aripiprazole Impurity A [ep Impurity]
47. D3599
48. Ft-0601230
49. 1,2,3,4-tetrahydroquinoline -7 -ol-2-one
50. 7-(hydroxyl)-3,4-dihydroquinolin-2(1h)-one
51. 7-hydroxy-1,2,3,4-tetrahydroquinoline-2-one
52. 7-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline
53. 246h180
54. 3,4-dihydro-7-hydroxyquinolin-2(1h)-one
55. 3,4-dihydro-7-hydroxyquinoline-2(1h)-one-[d6]
56. 7-hydroxy-3,4-dihydro-2(1h)-quinolinone, 97%
57. A816050
58. J-511190
59. 7-hydroxy-3,4-dihydroquinolin-2(1h)-one;7-hydroxy-3,4-dihydro Carbostyril;7-hydroxy-3,4-dihydro-2(1h)-quinolinone;7-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline;
60. 8hj
61. Aripiprazole Dihydro Quinolinone Impurity (usp); 7-hydroxycarbostyril; 3,4-dihydro-7-hydroxy-2(1h)-quinolinone; 7-hydroxy-3,4-dihydroquinolin-2(1h)-one
| Molecular Weight | 163.17 g/mol |
|---|---|
| Molecular Formula | C9H9NO2 |
| XLogP3 | 0.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 163.063328530 g/mol |
| Monoisotopic Mass | 163.063328530 g/mol |
| Topological Polar Surface Area | 49.3 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 193 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A 22246-18-0 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 22246-18-0, including repackagers and relabelers. The FDA regulates 22246-18-0 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 22246-18-0 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 22246-18-0 supplier is an individual or a company that provides 22246-18-0 active pharmaceutical ingredient (API) or 22246-18-0 finished formulations upon request. The 22246-18-0 suppliers may include 22246-18-0 API manufacturers, exporters, distributors and traders.
22246-18-0 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 22246-18-0 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 22246-18-0 GMP manufacturer or 22246-18-0 GMP API supplier for your needs.
A 22246-18-0 CoA (Certificate of Analysis) is a formal document that attests to 22246-18-0's compliance with 22246-18-0 specifications and serves as a tool for batch-level quality control.
22246-18-0 CoA mostly includes findings from lab analyses of a specific batch. For each 22246-18-0 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
22246-18-0 may be tested according to a variety of international standards, such as European Pharmacopoeia (22246-18-0 EP), 22246-18-0 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (22246-18-0 USP).
LOOKING FOR A SUPPLIER?
